The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Gastritis Treatment Market Research Report 2025
Synopsis
Chronic gastritis occurs when your stomach lining becomes inflamed. Bacteria, consuming too much alcohol, certain medications, chronic stress, or other immune system problems can lead to inflammation.
The global Chronic Gastritis Treatment market was valued at US$ 152 million in 2023 and is anticipated to reach US$ 206.1 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Gastritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Gastritis Treatment.
Report Scope
The Chronic Gastritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Gastritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Gastritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wuhan Senwayer Century
Hangzhou Vega
Katsura Chemical
SAURAV CHEMICALS
Alchem International
ROLABO OUTSOURCING
RESONANCE LABORATORIES
Lupin Ltd
AstraZeneca
Microbiotix
Cipla
Perrigo Pharmaceutical
Segment by Type
Antacids
H2 Antagonists
Proton Pump Inhibitors
Others
Segment by Application
Virus Infection
Irritant
Drug Stimulate
Stress
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Gastritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Chronic gastritis occurs when your stomach lining becomes inflamed. Bacteria, consuming too much alcohol, certain medications, chronic stress, or other immune system problems can lead to inflammation.
The global Chronic Gastritis Treatment market was valued at US$ 152 million in 2023 and is anticipated to reach US$ 206.1 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Gastritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Gastritis Treatment.
Report Scope
The Chronic Gastritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Gastritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Gastritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wuhan Senwayer Century
Hangzhou Vega
Katsura Chemical
SAURAV CHEMICALS
Alchem International
ROLABO OUTSOURCING
RESONANCE LABORATORIES
Lupin Ltd
AstraZeneca
Microbiotix
Cipla
Perrigo Pharmaceutical
Segment by Type
Antacids
H2 Antagonists
Proton Pump Inhibitors
Others
Segment by Application
Virus Infection
Irritant
Drug Stimulate
Stress
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Gastritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Gastritis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antacids
1.2.3 H2 Antagonists
1.2.4 Proton Pump Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Gastritis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Virus Infection
1.3.3 Irritant
1.3.4 Drug Stimulate
1.3.5 Stress
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Gastritis Treatment Market Perspective (2019-2030)
2.2 Chronic Gastritis Treatment Growth Trends by Region
2.2.1 Global Chronic Gastritis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Gastritis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Chronic Gastritis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Chronic Gastritis Treatment Market Dynamics
2.3.1 Chronic Gastritis Treatment Industry Trends
2.3.2 Chronic Gastritis Treatment Market Drivers
2.3.3 Chronic Gastritis Treatment Market Challenges
2.3.4 Chronic Gastritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Gastritis Treatment Players by Revenue
3.1.1 Global Top Chronic Gastritis Treatment Players by Revenue (2019-2024)
3.1.2 Global Chronic Gastritis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Gastritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Gastritis Treatment Revenue
3.4 Global Chronic Gastritis Treatment Market Concentration Ratio
3.4.1 Global Chronic Gastritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Gastritis Treatment Revenue in 2023
3.5 Chronic Gastritis Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Gastritis Treatment Product Solution and Service
3.7 Date of Enter into Chronic Gastritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Gastritis Treatment Breakdown Data by Type
4.1 Global Chronic Gastritis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Chronic Gastritis Treatment Forecasted Market Size by Type (2025-2030)
5 Chronic Gastritis Treatment Breakdown Data by Application
5.1 Global Chronic Gastritis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Chronic Gastritis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Gastritis Treatment Market Size (2019-2030)
6.2 North America Chronic Gastritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Gastritis Treatment Market Size by Country (2019-2024)
6.4 North America Chronic Gastritis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Gastritis Treatment Market Size (2019-2030)
7.2 Europe Chronic Gastritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Gastritis Treatment Market Size by Country (2019-2024)
7.4 Europe Chronic Gastritis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Gastritis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Chronic Gastritis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Gastritis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Gastritis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Gastritis Treatment Market Size (2019-2030)
9.2 Latin America Chronic Gastritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Gastritis Treatment Market Size by Country (2019-2024)
9.4 Latin America Chronic Gastritis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Gastritis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Chronic Gastritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wuhan Senwayer Century
11.1.1 Wuhan Senwayer Century Company Detail
11.1.2 Wuhan Senwayer Century Business Overview
11.1.3 Wuhan Senwayer Century Chronic Gastritis Treatment Introduction
11.1.4 Wuhan Senwayer Century Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.1.5 Wuhan Senwayer Century Recent Development
11.2 Hangzhou Vega
11.2.1 Hangzhou Vega Company Detail
11.2.2 Hangzhou Vega Business Overview
11.2.3 Hangzhou Vega Chronic Gastritis Treatment Introduction
11.2.4 Hangzhou Vega Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.2.5 Hangzhou Vega Recent Development
11.3 Katsura Chemical
11.3.1 Katsura Chemical Company Detail
11.3.2 Katsura Chemical Business Overview
11.3.3 Katsura Chemical Chronic Gastritis Treatment Introduction
11.3.4 Katsura Chemical Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.3.5 Katsura Chemical Recent Development
11.4 SAURAV CHEMICALS
11.4.1 SAURAV CHEMICALS Company Detail
11.4.2 SAURAV CHEMICALS Business Overview
11.4.3 SAURAV CHEMICALS Chronic Gastritis Treatment Introduction
11.4.4 SAURAV CHEMICALS Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.4.5 SAURAV CHEMICALS Recent Development
11.5 Alchem International
11.5.1 Alchem International Company Detail
11.5.2 Alchem International Business Overview
11.5.3 Alchem International Chronic Gastritis Treatment Introduction
11.5.4 Alchem International Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.5.5 Alchem International Recent Development
11.6 ROLABO OUTSOURCING
11.6.1 ROLABO OUTSOURCING Company Detail
11.6.2 ROLABO OUTSOURCING Business Overview
11.6.3 ROLABO OUTSOURCING Chronic Gastritis Treatment Introduction
11.6.4 ROLABO OUTSOURCING Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.6.5 ROLABO OUTSOURCING Recent Development
11.7 RESONANCE LABORATORIES
11.7.1 RESONANCE LABORATORIES Company Detail
11.7.2 RESONANCE LABORATORIES Business Overview
11.7.3 RESONANCE LABORATORIES Chronic Gastritis Treatment Introduction
11.7.4 RESONANCE LABORATORIES Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.7.5 RESONANCE LABORATORIES Recent Development
11.8 Lupin Ltd
11.8.1 Lupin Ltd Company Detail
11.8.2 Lupin Ltd Business Overview
11.8.3 Lupin Ltd Chronic Gastritis Treatment Introduction
11.8.4 Lupin Ltd Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.8.5 Lupin Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Chronic Gastritis Treatment Introduction
11.9.4 AstraZeneca Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.9.5 AstraZeneca Recent Development
11.10 Microbiotix
11.10.1 Microbiotix Company Detail
11.10.2 Microbiotix Business Overview
11.10.3 Microbiotix Chronic Gastritis Treatment Introduction
11.10.4 Microbiotix Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.10.5 Microbiotix Recent Development
11.11 Cipla
11.11.1 Cipla Company Detail
11.11.2 Cipla Business Overview
11.11.3 Cipla Chronic Gastritis Treatment Introduction
11.11.4 Cipla Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.11.5 Cipla Recent Development
11.12 Perrigo Pharmaceutical
11.12.1 Perrigo Pharmaceutical Company Detail
11.12.2 Perrigo Pharmaceutical Business Overview
11.12.3 Perrigo Pharmaceutical Chronic Gastritis Treatment Introduction
11.12.4 Perrigo Pharmaceutical Revenue in Chronic Gastritis Treatment Business (2019-2024)
11.12.5 Perrigo Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Chronic Gastritis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antacids
Table 3. Key Players of H2 Antagonists
Table 4. Key Players of Proton Pump Inhibitors
Table 5. Key Players of Others
Table 6. Global Chronic Gastritis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Chronic Gastritis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Chronic Gastritis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Chronic Gastritis Treatment Market Share by Region (2019-2024)
Table 10. Global Chronic Gastritis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Chronic Gastritis Treatment Market Share by Region (2025-2030)
Table 12. Chronic Gastritis Treatment Market Trends
Table 13. Chronic Gastritis Treatment Market Drivers
Table 14. Chronic Gastritis Treatment Market Challenges
Table 15. Chronic Gastritis Treatment Market Restraints
Table 16. Global Chronic Gastritis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Chronic Gastritis Treatment Market Share by Players (2019-2024)
Table 18. Global Top Chronic Gastritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Gastritis Treatment as of 2023)
Table 19. Ranking of Global Top Chronic Gastritis Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Chronic Gastritis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Gastritis Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Gastritis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Gastritis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Chronic Gastritis Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Chronic Gastritis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Chronic Gastritis Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Chronic Gastritis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Chronic Gastritis Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Chronic Gastritis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Chronic Gastritis Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Chronic Gastritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Chronic Gastritis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Chronic Gastritis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Chronic Gastritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Chronic Gastritis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Chronic Gastritis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Chronic Gastritis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Chronic Gastritis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Chronic Gastritis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Chronic Gastritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Chronic Gastritis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Gastritis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Gastritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Chronic Gastritis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Wuhan Senwayer Century Company Detail
Table 49. Wuhan Senwayer Century Business Overview
Table 50. Wuhan Senwayer Century Chronic Gastritis Treatment Product
Table 51. Wuhan Senwayer Century Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 52. Wuhan Senwayer Century Recent Development
Table 53. Hangzhou Vega Company Detail
Table 54. Hangzhou Vega Business Overview
Table 55. Hangzhou Vega Chronic Gastritis Treatment Product
Table 56. Hangzhou Vega Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 57. Hangzhou Vega Recent Development
Table 58. Katsura Chemical Company Detail
Table 59. Katsura Chemical Business Overview
Table 60. Katsura Chemical Chronic Gastritis Treatment Product
Table 61. Katsura Chemical Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 62. Katsura Chemical Recent Development
Table 63. SAURAV CHEMICALS Company Detail
Table 64. SAURAV CHEMICALS Business Overview
Table 65. SAURAV CHEMICALS Chronic Gastritis Treatment Product
Table 66. SAURAV CHEMICALS Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 67. SAURAV CHEMICALS Recent Development
Table 68. Alchem International Company Detail
Table 69. Alchem International Business Overview
Table 70. Alchem International Chronic Gastritis Treatment Product
Table 71. Alchem International Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 72. Alchem International Recent Development
Table 73. ROLABO OUTSOURCING Company Detail
Table 74. ROLABO OUTSOURCING Business Overview
Table 75. ROLABO OUTSOURCING Chronic Gastritis Treatment Product
Table 76. ROLABO OUTSOURCING Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 77. ROLABO OUTSOURCING Recent Development
Table 78. RESONANCE LABORATORIES Company Detail
Table 79. RESONANCE LABORATORIES Business Overview
Table 80. RESONANCE LABORATORIES Chronic Gastritis Treatment Product
Table 81. RESONANCE LABORATORIES Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 82. RESONANCE LABORATORIES Recent Development
Table 83. Lupin Ltd Company Detail
Table 84. Lupin Ltd Business Overview
Table 85. Lupin Ltd Chronic Gastritis Treatment Product
Table 86. Lupin Ltd Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 87. Lupin Ltd Recent Development
Table 88. AstraZeneca Company Detail
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Chronic Gastritis Treatment Product
Table 91. AstraZeneca Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Microbiotix Company Detail
Table 94. Microbiotix Business Overview
Table 95. Microbiotix Chronic Gastritis Treatment Product
Table 96. Microbiotix Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 97. Microbiotix Recent Development
Table 98. Cipla Company Detail
Table 99. Cipla Business Overview
Table 100. Cipla Chronic Gastritis Treatment Product
Table 101. Cipla Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 102. Cipla Recent Development
Table 103. Perrigo Pharmaceutical Company Detail
Table 104. Perrigo Pharmaceutical Business Overview
Table 105. Perrigo Pharmaceutical Chronic Gastritis Treatment Product
Table 106. Perrigo Pharmaceutical Revenue in Chronic Gastritis Treatment Business (2019-2024) & (US$ Million)
Table 107. Perrigo Pharmaceutical Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Gastritis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Gastritis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Antacids Features
Figure 4. H2 Antagonists Features
Figure 5. Proton Pump Inhibitors Features
Figure 6. Others Features
Figure 7. Global Chronic Gastritis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Chronic Gastritis Treatment Market Share by Application: 2023 VS 2030
Figure 9. Virus Infection Case Studies
Figure 10. Irritant Case Studies
Figure 11. Drug Stimulate Case Studies
Figure 12. Stress Case Studies
Figure 13. Others Case Studies
Figure 14. Chronic Gastritis Treatment Report Years Considered
Figure 15. Global Chronic Gastritis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Chronic Gastritis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Chronic Gastritis Treatment Market Share by Region: 2023 VS 2030
Figure 18. Global Chronic Gastritis Treatment Market Share by Players in 2023
Figure 19. Global Top Chronic Gastritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Gastritis Treatment as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Chronic Gastritis Treatment Revenue in 2023
Figure 21. North America Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Chronic Gastritis Treatment Market Share by Country (2019-2030)
Figure 23. United States Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Chronic Gastritis Treatment Market Share by Country (2019-2030)
Figure 27. Germany Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Chronic Gastritis Treatment Market Share by Region (2019-2030)
Figure 35. China Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Chronic Gastritis Treatment Market Share by Country (2019-2030)
Figure 43. Mexico Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Chronic Gastritis Treatment Market Share by Country (2019-2030)
Figure 47. Turkey Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Chronic Gastritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Wuhan Senwayer Century Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 50. Hangzhou Vega Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 51. Katsura Chemical Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 52. SAURAV CHEMICALS Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 53. Alchem International Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 54. ROLABO OUTSOURCING Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 55. RESONANCE LABORATORIES Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 56. Lupin Ltd Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 58. Microbiotix Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 59. Cipla Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 60. Perrigo Pharmaceutical Revenue Growth Rate in Chronic Gastritis Treatment Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
